Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC [Phase 3]
Phase 3 trial comparing MYL-1402O with Avastin in stage IV non-small cell lung cancer has completed with results posted.
-
FDA approval · 2021-01-29FDA Approved: ALECENSA — Supplemental Application (Genentech, Inc.)
FDA supplemental application submitted for Alecensa (alectinib hydrochloride) by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions [Phase 2]
Phase 2 trial evaluating pyrotinib plus thalidomide in advanced non-small-cell lung cancer with HER2 exon 20 insertions.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer [NA]
Phase II study on image-guided stereotactic ablative radiotherapy for non-small cell lung cancer; trial terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Pegilodecakin (LY3500518) + pembrolizumab versus pembrolizumab alone as first-line therapy in metastatic non-small …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating split-course chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating romidepsin plus erlotinib in stage III/IV non-small cell lung cancer has completed with results posted.
-
FDA approval · 2021-01-14FDA Approved: DOCETAXEL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for generic docetaxel. Docetaxel is a chemotherapy agent used to treat mu…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment [Phase 2]
A Phase 2 trial evaluating pyrotinib with pemetrexed and carboplatin as first-line therapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC [Phase 2]
Phase 2 trial evaluating nivolumab combined with radiotherapy in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) [Phase 2]
Phase 2 trial evaluating stereotactic radiosurgery or local ablation followed by erlotinib in non-small cell lung cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC [Phase 2]
Phase 2 trial evaluating almonertinib with concurrent radiotherapy in locally advanced EGFR-mutant non-small cell lung cancer (Stage III NSC…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating first-line anti-PD-1/PD-L1 monoclonal antibody plus chemotherapy with bronchoscopy-assisted interventional therap…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Navelbine And Radiotherapy in Locally Advanced Lung Cancer [Phase 2]
Phase 2 trial update for Navelbine with radiotherapy in locally advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Central Nervous System(CNS) Efficacy of Dacomitinib [Phase 2]
Phase 2 trial update assessing CNS efficacy of dacomitinib in non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). [Phase 2]
Phase 2 trial evaluating R1507 plus Erlotinib in non-squamous non-small cell lung cancer; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. [Phase 2]
Phase 2 trial evaluating LDK378 (brigatinib) in ALK-positive non-small cell lung cancer patients previously treated with alectinib has compl…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial of ASA404 or placebo with paclitaxel and carboplatin as first-line treatment for stage IIIb/IV non-small cell lung cancer; tri…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial assessing ASA404 plus docetaxel vs placebo plus docetaxel in second-line treatment of non-small cell lung cancer was termina…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for Carboplatin and Paclitaxel with or without MEDI-575 in untreated, advanced non-small cell lung cancer (Phase 1/2);…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung [NA]
Clinical trial of the NEUWAVE Flex Microwave Ablation System for primary soft tissue lung lesions was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating emibetuzumab in combination with ramucirumab in various advanced cancers, with completed status and results poste…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of anlotinib with immune checkpoint inhibitors in advanced non-small cell lung cancer patients wh…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase II open-label, multi-arm trial in Chinese patients with advanced non-small cell lung cancer tested AUY922, BYL719, INC280, LDK378, a…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients [Phase 2]
Phase 2 trial evaluating MK-3475 (pembrolizumab) with docetaxel versus docetaxel alone in non-small cell lung cancer has been completed with…